<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-00972</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0000463</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cellular Death and Stress Responses</subject><subject>Computational Biology/Sequence Motif Analysis</subject><subject>Molecular Biology/Bioinformatics</subject><subject>Neurological Disorders/Alzheimer Disease</subject></subj-group></article-categories><title-group><article-title>A Novel Motif Identified in Dependence Receptors</article-title><alt-title alt-title-type="running-head">DART Motif</alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>del Rio</surname><given-names>Gabriel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kane</surname><given-names>Darci J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ball</surname><given-names>Keith D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bredesen</surname><given-names>Dale E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="n101"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Buck Institute for Age Research, Novato, California, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Neurology, University of California San Francisco, San Francisco, California, United States of America</addr-line>       </aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Zwaka</surname><given-names>Thomas</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Baylor College of Medicine, United States of America</aff><author-notes><corresp id="n101">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">dbredesen@buckinstitute.org</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: Gd DB DK. Performed the experiments: Gd. Analyzed the data: Gd DK KB. Wrote the paper: Gd DB DK KB. Other: Proposed the original idea and performed the initial computational analysis described in this work: Gd. Participated in the design and coordination of the study and helped to draft and finalize the manuscript: DB. Read and approved the final manuscript: DB Gd DK KB. Participated in the computational analysis and in the preparation of the manuscript: DK. Participated in the computation analysis: KB.</p></fn><fn fn-type="current-aff" id="fn1"><label>¤</label><p>Current address: Universidad Nacional Autonoma de Mexico/Instituto de Fisiologia Celular, Biochemistry Department, Ciudad Universitaria, Mexico</p></fn><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>23</day><month>5</month><year>2007</year></pub-date><volume>2</volume><issue>5</issue><elocation-id>e463</elocation-id><history><date date-type="received"><day>26</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2007</year></date></history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2007</copyright-year><copyright-holder>del Rio et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Programmed cell death signaling is a critical feature of development, cellular turnover, oncogenesis, and neurodegeneration, among other processes. Such signaling may be transduced via specific receptors, either following ligand binding—to death receptors—or following the withdrawal of trophic ligands—from dependence receptors. Although dependence receptors display functional similarities, no common structural domains have been identified. Therefore, we employed the Multiple Expectation Maximization for Motif Elicitation and the Motif Alignment and Search Tool software programs to identify a novel transmembrane motif, dubbed dependence-associated receptor transmembrane (DART) motif, that is common to all described dependence receptors. Of 3,465 human transmembrane proteins, 25 (0.7%) display the DART motif. The predicted secondary structure features an alpha helical structure, with an unusually high percentage of valine residues. At least four of the proteins undergo regulated intramembrane proteolysis. To date, we have not identified a function for this putative domain. We speculate that the DART motif may be involved in protein processing, interaction with other proteins or lipids, or homomultimerization.</p></abstract><funding-group><funding-statement>This work was supported by a grant to the Buck Institute from American Bioscience, Inc., by NIH grants NS45093, AG12282 and NS33376 to DEB and by CoNaCyT grant SEP-2004-C01-47399/A-1 to GDR.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Protein evolution is rife with examples of structural and functional domains utilized by multiple proteins: for example, over 700 human proteins display SH3 domains, and over 450 proteins display PDZ domains. The identification of such common domains may hint at similarities in substructure, interactions, and potentially in function, for the various proteins displaying these domains. About 680 different domains have been documented to date in the proteomes of humans and other organisms (SMART database, <ext-link ext-link-type="uri" xlink:href="http://smart.embl-heidelberg.de/" xlink:type="simple">http://smart.embl-heidelberg.de/</ext-link>, <xref ref-type="bibr" rid="pone.0000463-Letunic1">[1]</xref>), and many of these domains appear, with some variation, in numerous proteins. Alternatively, the recognition of novel motifs may link proteins previously thought to be unrelated—e.g., suggesting a common function or interaction—and therefore may aid in the determination of both structure and function for proteins that display the novel motif.</p><p>We have previously described a set of receptors that induces apoptosis following ligand withdrawal, but inhibits apoptosis following the binding of trophic ligands <xref ref-type="bibr" rid="pone.0000463-Bredesen1">[2]</xref>–<xref ref-type="bibr" rid="pone.0000463-Bredesen2">[5]</xref>. These receptors have been referred to as dependence receptors. Such receptors play roles in neural development, tumorigenesis (including metastasis), neurodegeneration, and possibly in subapoptotic events such as neurite retraction and somal atrophy <xref ref-type="bibr" rid="pone.0000463-Bredesen1">[2]</xref>–<xref ref-type="bibr" rid="pone.0000463-Bredesen2">[5]</xref>.</p><p>To date, ten such receptors have been described (<xref ref-type="table" rid="pone-0000463-t001">Table 1</xref> and <xref ref-type="bibr" rid="pone.0000463-Bredesen1">[2]</xref>). These do not share any obvious structural similarity, nor do they display similar domains required for apoptosis induction. For example, Unc5H2 features a death domain in its intracytoplasmic region, but DCC does not; instead, apoptosis induction by DCC requires a short region in its intracytoplasmic domain (residues 1243–1264) that does not bear similarity to a death domain.</p><table-wrap id="pone-0000463-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.t001</object-id><label>Table 1</label><caption><title>Ten dependence receptors (plus orthologues) comprise the training set for the MEME query.</title></caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0000463-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" colspan="1" rowspan="1">Entry Name</td><td align="left" colspan="1" rowspan="1">Accession #/Species</td><td align="left" colspan="1" rowspan="1">Protein Name</td><td align="left" colspan="1" rowspan="1">TM Location</td><td align="left" colspan="1" rowspan="1">DART Location</td><td align="left" colspan="1" rowspan="1">Subcellular Location</td><td align="left" colspan="1" rowspan="1">Function (per Swiss-Prot)</td></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">A4</td><td align="left" colspan="1" rowspan="1">P05067 (Human)</td><td align="left" colspan="1" rowspan="1">Amyloid beta A4 protein</td><td align="left" colspan="1" rowspan="1">700-723</td><td align="left" colspan="1" rowspan="1">705-723</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Mutated in some cases of Alzheimer's Disease</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P79307 (Pig)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P12023 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q6RH29 (Canfa)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">ANDR</td><td align="left" colspan="1" rowspan="1">P10275 (Human)</td><td align="left" colspan="1" rowspan="1">Androgen receptor</td><td align="left" colspan="1" rowspan="1">690-919 (ligand-binding)</td><td align="left" colspan="1" rowspan="1">880-898</td><td align="left" colspan="1" rowspan="1">Nuclear</td><td align="left" colspan="1" rowspan="1">Regulation of eukaryotic gene expression in target tissues</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q9GKL7 (Pig)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P19091 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P49699 (Rabbit)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">DCC</td><td align="left" colspan="1" rowspan="1">P43146 (Human)</td><td align="left" colspan="1" rowspan="1">Netrin receptor DCC</td><td align="left" colspan="1" rowspan="1">1098-1122</td><td align="left" colspan="1" rowspan="1">1098-1116</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Receptor for netrin required for axon guidance</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P70211 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q63155 (Rat)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q91562 (Xeno)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">PTC1</td><td align="left" colspan="1" rowspan="1">Q13635 (Human)</td><td align="left" colspan="1" rowspan="1">Patched protein homolog 1</td><td align="left" colspan="1" rowspan="1"><bold>101-121</bold></td><td align="left" colspan="1" rowspan="1">101-119</td><td align="left" colspan="1" rowspan="1">Integral membrane protein</td><td align="left" colspan="1" rowspan="1">Receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH). May have a tumor suppressor function</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q61115 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">437-457</td><td align="left" colspan="1" rowspan="1">574-592</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q90693 (Chick)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">473-493</td><td align="left" colspan="1" rowspan="1">1029-1047</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q09614 (Caeel)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">502-522</td><td align="left" colspan="1" rowspan="1">1085-1103</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">548-568</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>578-598</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">749-769</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>1028-1048</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1056-1076</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>1084-1104</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1122-1141</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1155-1175</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">RET</td><td align="left" colspan="1" rowspan="1">P07949 (Human)</td><td align="left" colspan="1" rowspan="1">Proto-oncogene tyrosine-protein kinase receptor ret</td><td align="left" colspan="1" rowspan="1">636-657</td><td align="left" colspan="1" rowspan="1">637-655</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Part of GDNF receptor complex with tyrosine-protein kinase activity</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P35546 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q9EPA1 (Rat)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">O42362 (Brare)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TNR5</td><td align="left" colspan="1" rowspan="1">P25942 (Human)</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor receptor superfamily member 5</td><td align="left" colspan="1" rowspan="1">194-215</td><td align="left" colspan="1" rowspan="1">195-213</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Receptor for TNFSF5/CD40L</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P27512 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q28203 (Bovine)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q7YRL5 (Canfa)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TNR16</td><td align="left" colspan="1" rowspan="1">P08138 (Human)</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor receptor superfamily member 16</td><td align="left" colspan="1" rowspan="1">251-272</td><td align="left" colspan="1" rowspan="1">257-275</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Common neurotrophin receptor</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P07174 (Rat)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q9Z0W1 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">P18519 (Chick)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">UNC5A</td><td align="left" colspan="1" rowspan="1">Q6ZN44 (Human)</td><td align="left" colspan="1" rowspan="1">Netrin receptor UNC5A</td><td align="left" colspan="1" rowspan="1">307-327</td><td align="left" colspan="1" rowspan="1">309-327</td><td align="left" colspan="1" rowspan="1">Type I membrane protein</td><td align="left" colspan="1" rowspan="1">Receptor for netrin required for axon guidance</td></tr><tr><td align="left" colspan="1" rowspan="1">UNC5B</td><td align="left" colspan="1" rowspan="1">Q8IZJ1 (Human)</td><td align="left" colspan="1" rowspan="1">Netrin receptor UNC5B</td><td align="left" colspan="1" rowspan="1">378-398</td><td align="left" colspan="1" rowspan="1">381-399</td><td align="left" colspan="1" rowspan="1">Type I membrane protein (by similarity)</td><td align="left" colspan="1" rowspan="1">Receptor for netrin required for axon guidance (axon repulsion)</td></tr><tr><td align="left" colspan="1" rowspan="1">UNC5C</td><td align="left" colspan="1" rowspan="1">O95185 (Human)</td><td align="left" colspan="1" rowspan="1">Netrin receptor UNC5C</td><td align="left" colspan="1" rowspan="1">381-401</td><td align="left" colspan="1" rowspan="1">382-400</td><td align="left" colspan="1" rowspan="1">Type I membrane protein (by similarity)</td><td align="left" colspan="1" rowspan="1">Receptor for netrin required for axon guidance (repulsion)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">O08747 (Mouse)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>Ten dependence receptors plus their orthologues (32 sequences total) were used as a training set by the MEME program to search for high-scoring motifs common to all proteins. <xref ref-type="table" rid="pone-0000463-t001">Table 1</xref> shows the transmembrane location (for each protein with one) and the location of the DART motif. Data taken from the Swiss-Prot database. All accession numbers are from Swiss-Prot.</p></fn></table-wrap-foot></table-wrap><p>In the present study, we attempted to determine whether dependence receptors as a group may indeed display a common motif(s) that had gone undetected by the initial comparisons of alignment and predicted (known) domains. We utilized the Multiple EM (Expectation Maximization) for Motif Elicitation program (MEME) (<ext-link ext-link-type="uri" xlink:href="http://meme.sdsc.edu/meme/meme.html" xlink:type="simple">http://meme.sdsc.edu/meme/meme.html</ext-link> and <xref ref-type="bibr" rid="pone.0000463-Bailey1">[6]</xref>) and identified a novel motif that is featured by receptors that have been described as dependence receptors. We then searched the Swiss-Prot protein database (<ext-link ext-link-type="uri" xlink:href="http://www.expasy.uniprot.org/" xlink:type="simple">http://www.expasy.uniprot.org/</ext-link> and <xref ref-type="bibr" rid="pone.0000463-Boeckmann1">[7]</xref>) using the Motif Alignment and Search Tool (MAST) program (<ext-link ext-link-type="uri" xlink:href="http://meme.sdsc.edu/meme/mast.html" xlink:type="simple">http://meme.sdsc.edu/meme/mast.html</ext-link> and <xref ref-type="bibr" rid="pone.0000463-Bailey2">[8]</xref>), to determine whether other receptors or other proteins also feature this motif, and identified an additional 16 human proteins that display this motif (see <xref ref-type="sec" rid="s3">Results</xref> and Discussion, below).</p><p>The novel putative motif is in a transmembrane region, and therefore was dubbed dependence-associated receptor transmembrane motif (DART motif). Here we describe the consensus sequence and discuss the possible functions of this novel motif.</p></sec><sec id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Databases and software</title><p>The UniProt Knowledgebase (UniProtKB; <ext-link ext-link-type="uri" xlink:href="http://www.expasy.uniprot.org/" xlink:type="simple">http://www.expasy.uniprot.org/</ext-link>) database Release 3.3 (consisting of Swiss-Prot Release 45.3 and TrEMBL Release 28.3) from the Swiss Institute of Bioinformatics was used for this study. This database was chosen because it is well documented and allowed us to analyze the predictions on receptors.</p><p>The MEME (<ext-link ext-link-type="uri" xlink:href="http://meme.sdsc.edu/meme/meme.html" xlink:type="simple">http://meme.sdsc.edu/meme/meme.html</ext-link>) software program (version 3.0; non-commercial version) was used for the identification of motifs in non-aligned sequences, where a motif is a sequence pattern that occurs repeatedly in a group of protein or DNA sequences. MEME saves these motifs as a set of profiles. MEME uses the method of Bailey and Elkan to identify likely motifs within the input set of sequences <xref ref-type="bibr" rid="pone.0000463-Bailey1">[6]</xref>. A range of motif widths (&gt;15 amino acids in length) and various numbers of unique motifs to search for (zero or one motifs per sequence) were specified in our queries.</p><p>The software program MAST (<ext-link ext-link-type="uri" xlink:href="http://meme.sdsc.edu/meme/mast.html" xlink:type="simple">http://meme.sdsc.edu/meme/mast.html</ext-link>, version 3.0; non-commercial version) was used to search the Swiss-Prot database for other proteins displaying the motifs identified by MEME to be present in more than one dependence receptor. The algorithm in MAST calculates position scores for each profile at each possible position within a sequence. These scores are translated into p-values, which represent the likelihood of the given profile scoring that well against a randomly generated sequence. The best (i.e., lowest) position p-values for each profile are then adjusted to take into account the length of the sequence. MAST avoids allowing gaps in the profiles or in the search sequence.</p></sec><sec id="s2b"><title>Training Set</title><p>In order to search for motifs in previously described dependence receptors, we used a set of ten human receptors and their corresponding orthologues (three orthologues were used for each, in order to avoid bias generated by using more orthologues for one dependence receptor than another) found in the UniProtKB database. Thus, our training set included a total of 32 protein sequences (32 rather than 40, since the netrin receptors Unc5A, Unc5B, Unc5C were represented by a total of 4 sequences rather than 12, to prevent overweighting). This list is shown in <xref ref-type="table" rid="pone-0000463-t001">Table 1</xref>.</p><p>The option of having the training set sequences “shuffled” provided one of the controls used, ensuring that the motif(s) we detected were significant.</p></sec><sec id="s2c"><title>Web Site</title><p>To maintain updated information on the dependence receptor field and to allow researchers to identify the DART motif in their protein of interest, we have developed a website (<ext-link ext-link-type="uri" xlink:href="http://bis.ifc.unam.mx/DependenceReceptors/" xlink:type="simple">http://bis.ifc.unam.mx/DependenceReceptors/</ext-link>). The program at our website runs four independent predictions: three for identifying a transmembrane region and one for identifying the DART motif. The transmembrane region predictions are run through three different programs located at:</p><list list-type="order"><list-item><p>HMMTOP (<ext-link ext-link-type="uri" xlink:href="http://www.enzim.hu/hmmtop/" xlink:type="simple">http://www.enzim.hu/hmmtop/</ext-link>),</p></list-item><list-item><p>SOSUI (<ext-link ext-link-type="uri" xlink:href="http://sosui.proteome.bio.tuat.ac.jp/sosui_submit.html" xlink:type="simple">http://sosui.proteome.bio.tuat.ac.jp/sosui_submit.html</ext-link>) and</p></list-item><list-item><p>TMPRED (<ext-link ext-link-type="uri" xlink:href="http://www.ch.embnet.org/software/TMPRED_form.html" xlink:type="simple">http://www.ch.embnet.org/software/TMPRED_form.html</ext-link>).</p></list-item></list><p>For identifying the DART motif, the website uses the MAST program.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Searching for motifs among the known dependence receptors</title><p>The dependence receptors listed in <xref ref-type="table" rid="pone-0000463-t001">Table 1</xref> have all been shown to induce programmed cell death when expressed in the absence of their respective trophic ligands, but not when bound by these same trophic ligands. The receptors' non-orthologous sequences in the training set did not show any significant sequence similarity by simple alignment searches. Hence, in order to search for novel motifs in this set, we used the MEME program. MEME allows the identification of motifs in non-aligned sequences, where a motif is a sequence pattern that occurs repeatedly in a group of protein or DNA sequences (see <xref ref-type="sec" rid="s2">Materials and Methods</xref> section). Although MEME has been most commonly used to identify motifs in homologous sequences, a pattern identified by MEME in non-homologous sequences may be biologically relevant if: a) the proteins in the training set share a common function and b) the proteins identified to contain the motif could reasonably be suspected to share functional features with the training set. Note that these are the same conditions that are considered when evaluating motifs identified in homologous proteins.</p><p>Using a training set consisting of 32 sequences from the 10 experimentally-proven dependence receptors (<xref ref-type="table" rid="pone-0000463-t001">Table 1</xref>), we identified a novel motif that occurs in all of the training set proteins. This motif, designated “DART” (dependence-associated receptor transmembrane) motif, appeared in the transmembrane region of all proteins in the training set that include a transmembrane region, whereas it appeared in the ligand-binding region of the one protein that lacks a transmembrane region (the androgen receptor).</p><p>The consensus sequence of the proposed DART domain is shown in <xref ref-type="fig" rid="pone-0000463-g001">Figure 1</xref>, and the DART motifs from the training set proteins are aligned in <xref ref-type="fig" rid="pone-0000463-g002">Figure 2</xref>.</p><fig id="pone-0000463-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.g001</object-id><label>Figure 1</label><caption><title>Multilevel consensus sequence and amino acid frequency of the DART motif.</title><p>MEME motifs are represented by position-specific probability matrices that specify the probability of each possible letter appearing at each possible position in an occurrence of the motif. In order to make it easier to see which letters are most likely in each of the columns of the motif, the simplified motif shows the letter probabilities multiplied by 10 rounded to the nearest integer. Zeros are replaced by “:” (a colon) for readability. The information content diagram provides an idea of which positions in the motif are most highly conserved. Each column (position) in a motif can be characterized by the amount of information it contains (measured in bits). Highly conserved positions in the motif have high information; positions where all letters are equally likely have low information. The diagram is printed so that each column lines up with the same column in the simplified position-specific probability matrix above it. This multilevel consensus sequence says several things about the motif. First, the most likely form of the motif can be read from the top line as LLVIAVVVALVIxVLLVxL. Second, that only letter L has probability more than 0.2 in position 1 of the motif, both L and I have probability greater than 0.2 in position 2, etc. Third, a rough approximation of the motif can be made by converting the multilevel consensus sequence into the Prosite signature: L-[LI]-V-I-[AS]-V-V-V-[AGS]-L-V-[IF]-x-[VI]-L-[LV]-V-x-[LI].</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.g001" xlink:type="simple"/></fig><fig id="pone-0000463-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.g002</object-id><label>Figure 2</label><caption><title>Aligned DART motif within all dependence receptor training set members.</title><p>Occurrences (sites) of the DART motif within the sequences of the 32 dependence receptors that were used as the training set. The sites are shown aligned with each other, and the ten sequence positions preceding and following each site are also shown. Each site is identified by the name of the sequence where it occurs and the position in the sequence where the site begins. The sites are listed in order of increasing p-value (decreasing statistical significance). The p-value of a site is computed from the match score of the site with the position specific scoring matrix for the motif. The p-value gives the probability of a random string (generated from the background letter frequencies) having the same match score or higher. Amino acid residues constituting the transmembrane region of the protein are indicated by shading.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.g002" xlink:type="simple"/></fig><p>Using the software program MAST to search the Swiss-Prot database for other proteins that displayed the DART motif, we found an additional 54 sequences, 16 of which are human proteins (using a cut-off at E-value of 2.7, the value below which all training set members scored) (<xref ref-type="table" rid="pone-0000463-t002">Table 2</xref>). Of 13,991 human proteins in the database, 3,465 are annotated as transmembrane proteins, and 25 display the DART motif—nine of the 10 training set members (the exception being, as noted above, the androgen receptor) and 16 additional human proteins (<xref ref-type="table" rid="pone-0000463-t003">Table 3</xref>). Of these 16 additional proteins, all were transmembrane proteins, and all contained the DART motif within their transmembrane region. Thus the DART motif is relatively uncommon (at least as defined here), occurring in approximately 0.7% of human transmembrane proteins (25/3465). If we include slightly less similar motifs, extending the acceptable E-value from 2.7 to 10, then an additional 4 human proteins are included (data not shown). The alignment of the putative DART domains of these 16 human non-training set proteins is shown in <xref ref-type="fig" rid="pone-0000463-g003">Figure 3</xref>. A dendrogram of the human DART motifs is shown in <xref ref-type="fig" rid="pone-0000463-g004">Figure 4</xref>.</p><fig id="pone-0000463-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.g003</object-id><label>Figure 3</label><caption><title>Aligned DART motif within 26 human proteins.</title><p>Occurrences (sites) of the DART motif within the sequences of the 10 human dependence receptors from the training set (top 10 of list) and the 16 human proteins designated by MAST as containing the motif. The sites are shown aligned with each other, and the ten sequence positions preceding and following each site are also shown. Each site is identified by the name of the sequence where it occurs and the position in the sequence where the site begins. The sites are listed in order of increasing p-value. The p-value of a site is computed from the match score of the site with the position specific scoring matrix for the motif. The p-value gives the probability of a random string (generated from the background letter frequencies) having the same match score or higher. Amino acid residues constituting the transmembrane region of the protein are indicated by shading.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.g003" xlink:type="simple"/></fig><fig id="pone-0000463-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.g004</object-id><label>Figure 4</label><caption><title>Dendrogram of the 26 human DART-containing proteins.</title><p>Dendrogram demonstrating the relationships of the DART motif sequences within each of the 26 human proteins found to contain DART (10 from the training set plus 16 discovered through the use of MAST).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.g004" xlink:type="simple"/></fig><table-wrap id="pone-0000463-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.t002</object-id><label>Table 2</label><caption><title>MAST result list of 54 non-training set proteins found to display the DART motif.</title></caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0000463-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.t002" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" colspan="1" rowspan="1">Swiss-Prot Accession # / Sequence Name</td><td align="left" colspan="1" rowspan="1">Protein Name (truncated)</td></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">sp|Q05910|ADAM8_MOUSE</td><td align="left" colspan="1" rowspan="1">ADAM 8 precursor (A disin…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q06335|APLP2_MOUSE</td><td align="left" colspan="1" rowspan="1">Amyloid-like protein 2 pr…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q06481|APLP2_HUMAN</td><td align="left" colspan="1" rowspan="1">Amyloid-like protein 2 pr…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P15943|APLP2_RAT</td><td align="left" colspan="1" rowspan="1">Amyloid-like protein 2 pr…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9JKC6|BM88_MOUSE</td><td align="left" colspan="1" rowspan="1">BM88 antigen</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q8N111|BM88_HUMAN</td><td align="left" colspan="1" rowspan="1">BM88 antigen</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q29026|BM88_PIG</td><td align="left" colspan="1" rowspan="1">BM88 antigen</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P21964|COMT_HUMAN</td><td align="left" colspan="1" rowspan="1">Catechol O-methyltransfer…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q12215|WSC3_YEAST</td><td align="left" colspan="1" rowspan="1">Cell wall integrity and s…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P22521|IMMV_ECOLI</td><td align="left" colspan="1" rowspan="1">Colicin V immunity protei…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P18466|HA19_CANFA</td><td align="left" colspan="1" rowspan="1">DLA CLASS I HISTOCOMPATIB…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P54753|EPHB3_HUMAN</td><td align="left" colspan="1" rowspan="1">Ephrin type-B receptor 3 …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q07498|EPHB3_CHICK</td><td align="left" colspan="1" rowspan="1">Ephrin type-B receptor 3 …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q91735|EPHB3_XENLA</td><td align="left" colspan="1" rowspan="1">Ephrin type-B receptor 3 …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P54761|EPHB4_MOUSE</td><td align="left" colspan="1" rowspan="1">Ephrin type-B receptor 4 …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P04855|FUS_SENDZ</td><td align="left" colspan="1" rowspan="1">Fusion glycoprotein F0 pr…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P18345|VGLE_EHV4</td><td align="left" colspan="1" rowspan="1">Glycoprotein E</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P32343|YKM4_YEAST</td><td align="left" colspan="1" rowspan="1">Hypothetical 65.1 kDa pro…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|O13785|YEO7_SCHPO</td><td align="left" colspan="1" rowspan="1">Hypothetical protein C17G…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q21874|YF1M_CAEEL</td><td align="left" colspan="1" rowspan="1">Hypothetical protein R09E…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q83S36|YBHG_SHIFL</td><td align="left" colspan="1" rowspan="1">Hypothetical UPF0194 memb…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q8FJN6|YBHG_ECOL6</td><td align="left" colspan="1" rowspan="1">Hypothetical UPF0194 memb…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P75777|YBHG_ECOLI</td><td align="left" colspan="1" rowspan="1">Hypothetical UPF0194 memb…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q8X7Y9|YBHG_ECO57</td><td align="left" colspan="1" rowspan="1">Hypothetical UPF0194 memb…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P78552|I13R1_HUMAN</td><td align="left" colspan="1" rowspan="1">Interleukin-13 receptor a…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P16150|LEUK_HUMAN</td><td align="left" colspan="1" rowspan="1">Leukosialin precursor (Le…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P50895|LU_HUMAN</td><td align="left" colspan="1" rowspan="1">Lutheran blood group glyc…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P32334|MSB2_YEAST</td><td align="left" colspan="1" rowspan="1">MSB2 protein (Multicopy s…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9HZL1|NQRF_PSEAE</td><td align="left" colspan="1" rowspan="1">Na(+)-translocating NADH-…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P97798|NEO1_MOUSE</td><td align="left" colspan="1" rowspan="1">Neogenin precursor</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q92859|NEO1_HUMAN</td><td align="left" colspan="1" rowspan="1">Neogenin precursor</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9UM47|NOTC3_HUMAN</td><td align="left" colspan="1" rowspan="1">Neurogenic locus notch ho…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P46697|PPIB_MYCLE</td><td align="left" colspan="1" rowspan="1">Probable peptidyl-prolyl …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P50605|SDC_CAEEL</td><td align="left" colspan="1" rowspan="1">Probable syndecan precurs…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P20990|VA13_VACCC</td><td align="left" colspan="1" rowspan="1">Protein A13</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P33838|VA13_VARV</td><td align="left" colspan="1" rowspan="1">Protein A13</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|O15165|C181_HUMAN</td><td align="left" colspan="1" rowspan="1">Protein C18orf1</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q53902|MMLA_STRCO</td><td align="left" colspan="1" rowspan="1">Putative membrane protein…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P06494|ERBB2_RAT</td><td align="left" colspan="1" rowspan="1">Receptor tyrosine-protein…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q8E6G4|EZRA_STRA3</td><td align="left" colspan="1" rowspan="1">Septation ring formation …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P49415|SDC_DROME</td><td align="left" colspan="1" rowspan="1">Syndecan precursor</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P26260|SDC1_RAT</td><td align="left" colspan="1" rowspan="1">Syndecan-1 precursor (SYN…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P18828|SDC1_MOUSE</td><td align="left" colspan="1" rowspan="1">Syndecan-1 precursor (SYN…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q64704|STX3_MOUSE</td><td align="left" colspan="1" rowspan="1">Syntaxin-3</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q08849|STX3_RAT</td><td align="left" colspan="1" rowspan="1">Syntaxin-3</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q13277|STX3_HUMAN</td><td align="left" colspan="1" rowspan="1">Syntaxin-3</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P13726|TF_HUMAN</td><td align="left" colspan="1" rowspan="1">Tissue factor precursor (…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9D7R2|TMEPA_MOUSE</td><td align="left" colspan="1" rowspan="1">Transmembrane prostate an…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|O14763|TR10B_HUMAN</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor rec…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9UBN6|TR10D_HUMAN</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor rec…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|P09758|TACD2_HUMAN</td><td align="left" colspan="1" rowspan="1">Tumor-associated calcium …</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|O70404|VAM8_MOUSE</td><td align="left" colspan="1" rowspan="1">Vesicle-associated membra…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|Q9WUF4|VAM8_RAT</td><td align="left" colspan="1" rowspan="1">Vesicle-associated membra…</td></tr><tr><td align="left" colspan="1" rowspan="1">sp|O95183|VAM5_HUMAN</td><td align="left" colspan="1" rowspan="1">Vesicle-associated membra…</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><p>The top-scoring non-training-set proteins displaying the DART motif, representing 38 proteins (plus 16 orthologues). Sixteen of the 54 are the human proteins listed in <xref ref-type="table" rid="pone-0000463-t003">Table 3</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0000463-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.t003</object-id><label>Table 3</label><caption><title>16 human proteins found to display the DART motif.</title></caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0000463-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.t003" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" colspan="1" rowspan="1">Entry Name</td><td align="left" colspan="1" rowspan="1">Accession #</td><td align="left" colspan="1" rowspan="1">Protein Name</td><td align="left" colspan="1" rowspan="1">TM Location</td><td align="left" colspan="1" rowspan="1">DART Location</td><td align="left" colspan="1" rowspan="1">Subcellular Location</td><td align="left" colspan="1" rowspan="1">Function (per Swiss-Prot)</td></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">APLP2</td><td align="left" colspan="1" rowspan="1">Q06481</td><td align="left" colspan="1" rowspan="1">Amyloid-like protein 2 [Precursor]</td><td align="left" colspan="1" rowspan="1">693-716</td><td align="left" colspan="1" rowspan="1">698-716</td><td align="left" colspan="1" rowspan="1">Type I membrane protein (MP)</td><td align="left" colspan="1" rowspan="1">May play a role in the regulation of hemostasis</td></tr><tr><td align="left" colspan="1" rowspan="1">CS001</td><td align="left" colspan="1" rowspan="1">O15165</td><td align="left" colspan="1" rowspan="1">Protein C18orf1</td><td align="left" colspan="1" rowspan="1">65-85</td><td align="left" colspan="1" rowspan="1">67-85</td><td align="left" colspan="1" rowspan="1">Type Ib MP</td><td align="left" colspan="1" rowspan="1">May confer susceptibility to schizophrenia</td></tr><tr><td align="left" colspan="1" rowspan="1">BM88</td><td align="left" colspan="1" rowspan="1">Q8N111</td><td align="left" colspan="1" rowspan="1">BM88 antigen</td><td align="left" colspan="1" rowspan="1">126-146</td><td align="left" colspan="1" rowspan="1">126-144</td><td align="left" colspan="1" rowspan="1">Type IV MP</td><td align="left" colspan="1" rowspan="1">Involved in neuroblastoma cell differentiation (by similarity)</td></tr><tr><td align="left" colspan="1" rowspan="1">NOTC3</td><td align="left" colspan="1" rowspan="1">Q9UM47</td><td align="left" colspan="1" rowspan="1">Neurogenic locus notch homolog protein 3</td><td align="left" colspan="1" rowspan="1">1644-1664</td><td align="left" colspan="1" rowspan="1">1646-1664</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination</td></tr><tr><td align="left" colspan="1" rowspan="1">EPHB3</td><td align="left" colspan="1" rowspan="1">P54753</td><td align="left" colspan="1" rowspan="1">Ephrin type-B receptor 3</td><td align="left" colspan="1" rowspan="1">560-580</td><td align="left" colspan="1" rowspan="1">559-577</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Receptor for members of the ephrin-B family</td></tr><tr><td align="left" colspan="1" rowspan="1">TR10B</td><td align="left" colspan="1" rowspan="1">O14763</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor receptor superfamily member 10B</td><td align="left" colspan="1" rowspan="1">211-231</td><td align="left" colspan="1" rowspan="1">213-231</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Receptor for TNFSF10/TRAIL</td></tr><tr><td align="left" colspan="1" rowspan="1">I13R1</td><td align="left" colspan="1" rowspan="1">P78552</td><td align="left" colspan="1" rowspan="1">Interleukin-13 receptor alpha-1 chain</td><td align="left" colspan="1" rowspan="1">344-367</td><td align="left" colspan="1" rowspan="1">349-367</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Binds IL13 with a low affinity</td></tr><tr><td align="left" colspan="1" rowspan="1">TF</td><td align="left" colspan="1" rowspan="1">P13726</td><td align="left" colspan="1" rowspan="1">Tissue factor</td><td align="left" colspan="1" rowspan="1">252-274</td><td align="left" colspan="1" rowspan="1">254-272</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Initiates blood coagulation by forming a complex with circulating factor VII or VIIa</td></tr><tr><td align="left" colspan="1" rowspan="1">TR10D</td><td align="left" colspan="1" rowspan="1">Q9UBN6</td><td align="left" colspan="1" rowspan="1">Tumor necrosis factor receptor superfamily member 10D</td><td align="left" colspan="1" rowspan="1">212-232</td><td align="left" colspan="1" rowspan="1">212-230</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Receptor for TRAIL</td></tr><tr><td align="left" colspan="1" rowspan="1">LU</td><td align="left" colspan="1" rowspan="1">P50895</td><td align="left" colspan="1" rowspan="1">Lutheran blood group glycoprotein</td><td align="left" colspan="1" rowspan="1">548-568</td><td align="left" colspan="1" rowspan="1">551-569</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Probable receptor. May mediate intracellular signaling. Member of the immunoglobulin superfamily IG</td></tr><tr><td align="left" colspan="1" rowspan="1">STX3</td><td align="left" colspan="1" rowspan="1">Q13277</td><td align="left" colspan="1" rowspan="1">Syntaxin-3</td><td align="left" colspan="1" rowspan="1">264-284</td><td align="left" colspan="1" rowspan="1">264-282</td><td align="left" colspan="1" rowspan="1">Type IV MP</td><td align="left" colspan="1" rowspan="1">Potentially involved in docking of synaptic vesicles at presynaptic active zones</td></tr><tr><td align="left" colspan="1" rowspan="1">VAMP5</td><td align="left" colspan="1" rowspan="1">O95183</td><td align="left" colspan="1" rowspan="1">Vesicle-associated membrane protein 5</td><td align="left" colspan="1" rowspan="1">73-93</td><td align="left" colspan="1" rowspan="1">75-93</td><td align="left" colspan="1" rowspan="1">Type IV MP</td><td align="left" colspan="1" rowspan="1">May participate in trafficking events that are associated with myogenesis</td></tr><tr><td align="left" colspan="1" rowspan="1">COMT</td><td align="left" colspan="1" rowspan="1">P21964</td><td align="left" colspan="1" rowspan="1">Catechol O-methyltransferase</td><td align="left" colspan="1" rowspan="1">7-26</td><td align="left" colspan="1" rowspan="1">7-25</td><td align="left" colspan="1" rowspan="1">Type II MP</td><td align="left" colspan="1" rowspan="1">Catalyzes the O-methylation of catecholamine neurotransmitters and catechol hormones</td></tr><tr><td align="left" colspan="1" rowspan="1">LEUK</td><td align="left" colspan="1" rowspan="1">P16150</td><td align="left" colspan="1" rowspan="1">Leukosialin</td><td align="left" colspan="1" rowspan="1">254-276</td><td align="left" colspan="1" rowspan="1">255-273</td><td align="left" colspan="1" rowspan="1">Type I MP.</td><td align="left" colspan="1" rowspan="1">Physicochemical properties of the T-cell surface and lectin binding</td></tr><tr><td align="left" colspan="1" rowspan="1">NEO1</td><td align="left" colspan="1" rowspan="1">Q92859</td><td align="left" colspan="1" rowspan="1">Neogenin</td><td align="left" colspan="1" rowspan="1">1106-1126</td><td align="left" colspan="1" rowspan="1">1104-1122</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">Receptor for repulsive guidance molecule</td></tr><tr><td align="left" colspan="1" rowspan="1">TACD2</td><td align="left" colspan="1" rowspan="1">P09758</td><td align="left" colspan="1" rowspan="1">Tumor-associated calcium signal transducer 2</td><td align="left" colspan="1" rowspan="1">275-297</td><td align="left" colspan="1" rowspan="1">277-295</td><td align="left" colspan="1" rowspan="1">Type I MP</td><td align="left" colspan="1" rowspan="1">May function as growth factor receptor</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><p>Sixteen human proteins were discovered that display high-scoring matches for the DART motif when the Swiss-Prot database was searched using the MAST software program. <xref ref-type="table" rid="pone-0000463-t003">Table 3</xref> shows the transmembrane location and the location of the DART motif. Data taken from the Swiss-Prot database. All accession numbers are from Swiss-Prot.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Structure of the putative DART domain</title><p>The predicted secondary structure of the consensus DART domain, as predicted by the SOPMA (Self Optimized Prediction Method from Alignments) method <xref ref-type="bibr" rid="pone.0000463-Combet1">[9]</xref> is for a helical structure (<xref ref-type="fig" rid="pone-0000463-g005">Figure 5</xref>). This is not surprising, given that the motif lies within the transmembrane region of the proteins that display it. However, in comparison to other transmembrane regions (in randomly selected transmembrane proteins) it is valine rich (29±4% vs. 15±3%; p&lt;0.001).</p><fig id="pone-0000463-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000463.g005</object-id><label>Figure 5</label><caption><title>Predicted secondary structure of the consensus sequence of DART.</title><p>SOPMA analysis demonstrates the alpha-helical nature of the putative DART domain.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0000463.g005" xlink:type="simple"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>The function of this novel motif is currently unknown. The finding that it exists in all dependence receptors described to date suggests that it may play a role in some biochemical process related to their function, such as the induction of apoptosis or the inhibition of apoptosis following ligand binding, or possibly an interaction with another membrane protein or membrane-associated non-proteinaceous molecule such as a lipid. For at least three of the proteins in the training set—APP, p75NTR, and DCC—this region undergoes regulated intramembrane proteolysis (RIP) <xref ref-type="bibr" rid="pone.0000463-Brown1">[10]</xref>, releasing an intracytoplasmic fragment that may migrate to the nucleus. Thus it is possible that the other proteins that display the DART motif may be substrates that also undergo regulated intramembrane proteolysis; however, a number of proteins that have been shown to undergo such cleavage do not display a DART motif, so it is clearly not required for such processing.</p><p>It is noteworthy that the transmembrane regions of DART-containing proteins are valine rich, with nearly twice the percentage of valine residues present in randomly-selected human Type I transmembrane protein domains (29±4% vs. 15±3%; p&lt;0.001). It has been shown that Leu heptads within transmembrane domains may serve as homomultimerization domains and that the substitution of Ala (or other residues typical of transmembrane regions, including Val) for Leu may prevent homomultimerization <xref ref-type="bibr" rid="pone.0000463-Gurezka1">[11]</xref>. Thus one possibility for the Val-rich nature of the DART domain may relate to the inhibition of receptor homomultimerization.</p><sec id="s4a"><title>Proteins identified by MAST as displaying the DART motif</title><p>As noted above, MAST identified 16 proteins, all transmembrane proteins displaying the DART motifs and were as similar to the consensus as those of the training set (<xref ref-type="table" rid="pone-0000463-t003">Table 3</xref>; <xref ref-type="fig" rid="pone-0000463-g003">Figure 3</xref>). Most of these have been implicated in cell death, either directly or indirectly; furthermore, several bind trophic ligands, as well, making them reasonable candidates to evaluate experimentally as possible dependence receptors.</p><p>Neogenin has recently been shown to bind RGM (repulsive guidance molecule), and to serve as a possible dependence receptor for RGM, inducing programmed cell death that is inhibited by RGM <xref ref-type="bibr" rid="pone.0000463-Matsunaga1">[12]</xref>. Therefore, the identification of a DART motif within neogenin provides further support for RGM as a candidate dependence receptor.</p><p>APLP2 (APP-like protein 2) has been shown previously to be similar to APP in displaying a potential caspase-cleavage site in its intracytoplasmic domain <xref ref-type="bibr" rid="pone.0000463-Galvan1">[13]</xref>. Cleavage at this site liberates a pro-apoptotic peptide, C31, similar to what has been demonstrated for APP. Thus, although it is not yet clear whether APLP2 functions as a dependence receptor, and in particular whether APLP2 binds a trophic ligand, by analogy to APP it may bind laminin, collagen IV, glypican, or another ligand <xref ref-type="bibr" rid="pone.0000463-Beher1">[14]</xref>–<xref ref-type="bibr" rid="pone.0000463-Williamson1">[16]</xref>, and thus serve as a dependence receptor for one or more of those ligands.</p><p>Notch is an extensively-studied transmembrane receptor involved in cell fate determination. It binds to ligands Delta1, Jagged1, and Jagged2, regulating differentiation, proliferation, and apoptosis. Notch, like APP, DCC, and p75NTR, undergoes regulated intramembrane proteolysis, liberating an intracytoplasmic domain, the NICD, that forms a transcriptional activator complex with RBP-J kappa, activating genes of the enhancer of split locus.</p><p>Ephrin type B receptor 3 binds both ephrin-B1 and ephrin-B2. It is not yet known whether this receptor induces programmed cell death in the absence of ephrin-B1 or –B2 binding.</p><p>Tumor-associated calcium signal transducer 2 (TACD2) may function as a trophic factor receptor, but its ligand is currently unknown.</p><p>Three of the proteins identified by MAST as displaying a DART motif are involved in neurotransmitter synthesis or release. Catechol O-methyltransferase exists in both cytosolic and membrane-spanning (type II membrane protein) forms, and this latter displays a DART motif. Syntaxin-3 is a Type IV membrane protein potentially involved in docking of synaptic vesicles at presynaptic active zones. Vesicle-associated membrane protein 5 (VAMP5) is also a Type IV membrane protein that may participate in vesicle trafficking events associated with myogenesis.</p></sec><sec id="s4b"><title>Conclusion</title><p>Ten of ten previously described dependence receptors display a region of similarity dubbed the DART (dependence-associated receptor transmembrane) motif. MAST identified this motif in an additional 16 human proteins in the SwissProt database, in all cases in the transmembrane regions. The function of this novel putative domain is unknown, but the motif is noted to be valine rich, and in at least four cases, the DART motif is a site of regulated intramembrane proteolysis (RIP). Whether or not this motif plays a functional role in cell death induction or ligand-induced inhibition mediated by dependence receptors remains to be determined, but the identification of this motif in 16 non-training-set proteins such as Notch and APLP2 raises the question of whether these proteins may also function as dependence receptors. Since the field of dependence receptors is an emerging field, we have developed a website for predicting dependence receptors at <ext-link ext-link-type="uri" xlink:href="http://bis.ifc.unam.mx/DependenceReceptors/" xlink:type="simple">http://bis.ifc.unam.mx/DependenceReceptors/</ext-link>.</p></sec></sec></body><back><ack><p>We thank Professor Mark Van der Laan (University of California, Berkeley, and the Buck Institute for Age Research) for his helpful discussions and assistance with data analysis.</p></ack><ref-list><title>References</title><ref id="pone.0000463-Letunic1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Letunic</surname><given-names>I</given-names></name><name name-style="western"><surname>Copley</surname><given-names>RR</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>S</given-names></name><name name-style="western"><surname>Ciccarelli</surname><given-names>FD</given-names></name><name name-style="western"><surname>Doerks</surname><given-names>T</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>SMART 4.0: towards genomic data integration.</article-title>             <source>Nucleic Acids Res</source>             <volume>32</volume>             <fpage>D142</fpage>             <lpage>144</lpage>          </element-citation></ref><ref id="pone.0000463-Bredesen1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bredesen</surname><given-names>DE</given-names></name><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Rabizadeh</surname><given-names>S</given-names></name></person-group>             <year>2004</year>             <article-title>Apoptosis and dependence receptors: a molecular basis for cellular addiction.</article-title>             <source>Physiol Rev</source>             <volume>84</volume>             <fpage>411</fpage>             <lpage>430</lpage>          </element-citation></ref><ref id="pone.0000463-Mehlen1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Bredesen</surname><given-names>DE</given-names></name></person-group>             <year>2004</year>             <article-title>The dependence receptor hypothesis.</article-title>             <source>Apoptosis</source>             <volume>9</volume>             <fpage>37</fpage>             <lpage>49</lpage>          </element-citation></ref><ref id="pone.0000463-Mehlen2"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Bredesen</surname><given-names>DE</given-names></name></person-group>             <year>2003</year>             <article-title>Meeting report: cellular dependence–old concept, new mechanisms.</article-title>             <source>Sci STKE</source>             <volume>2003</volume>             <fpage>pe55</fpage>          </element-citation></ref><ref id="pone.0000463-Bredesen2"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bredesen</surname><given-names>DE</given-names></name><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Rabizadeh</surname><given-names>S</given-names></name></person-group>             <year>2005</year>             <article-title>Receptors that mediate cellular dependence.</article-title>             <source>Cell Death Differ</source>             <volume>12</volume>             <fpage>1031</fpage>             <lpage>1043</lpage>          </element-citation></ref><ref id="pone.0000463-Bailey1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>TL</given-names></name><name name-style="western"><surname>Elkan</surname><given-names>C</given-names></name></person-group>             <year>1994</year>             <article-title>Fitting a mixture model by expectation maximization to discover motifs in biopolymers.</article-title>             <source>Proc Int Conf Intell Syst Mol Biol</source>             <volume>2</volume>             <fpage>28</fpage>             <lpage>36</lpage>          </element-citation></ref><ref id="pone.0000463-Boeckmann1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Boeckmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name><name name-style="western"><surname>Apweiler</surname><given-names>R</given-names></name><name name-style="western"><surname>Blatter</surname><given-names>MC</given-names></name><name name-style="western"><surname>Estreicher</surname><given-names>A</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003.</article-title>             <source>Nucleic Acids Res</source>             <volume>31</volume>             <fpage>365</fpage>             <lpage>370</lpage>          </element-citation></ref><ref id="pone.0000463-Bailey2"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>TL</given-names></name><name name-style="western"><surname>Gribskov</surname><given-names>M</given-names></name></person-group>             <year>1998</year>             <article-title>Combining evidence using p-values: application to sequence homology searches.</article-title>             <source>Bioinformatics</source>             <volume>14</volume>             <fpage>48</fpage>             <lpage>54</lpage>          </element-citation></ref><ref id="pone.0000463-Combet1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Combet</surname><given-names>C</given-names></name><name name-style="western"><surname>Blanchet</surname><given-names>C</given-names></name><name name-style="western"><surname>Geourjon</surname><given-names>C</given-names></name><name name-style="western"><surname>Deleage</surname><given-names>G</given-names></name></person-group>             <year>2000</year>             <article-title>NPS@: network protein sequence analysis</article-title>             <source>Trends Biochem Sci</source>             <volume>25</volume>             <fpage>147</fpage>             <lpage>150</lpage>          </element-citation></ref><ref id="pone.0000463-Brown1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ye</surname><given-names>J</given-names></name><name name-style="western"><surname>Rawson</surname><given-names>RB</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>JL</given-names></name></person-group>             <year>2000</year>             <article-title>Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans.</article-title>             <source>Cell</source>             <volume>100</volume>             <fpage>391</fpage>             <lpage>398</lpage>          </element-citation></ref><ref id="pone.0000463-Gurezka1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gurezka</surname><given-names>R</given-names></name><name name-style="western"><surname>Laage</surname><given-names>R</given-names></name><name name-style="western"><surname>Brosig</surname><given-names>B</given-names></name><name name-style="western"><surname>Langosch</surname><given-names>D</given-names></name></person-group>             <year>1999</year>             <article-title>A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments.</article-title>             <source>J Biol Chem</source>             <volume>274</volume>             <fpage>9265</fpage>             <lpage>9270</lpage>          </element-citation></ref><ref id="pone.0000463-Matsunaga1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matsunaga</surname><given-names>E</given-names></name><name name-style="western"><surname>Tauszig-Delamasure</surname><given-names>S</given-names></name><name name-style="western"><surname>Monnier</surname><given-names>PP</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>BK</given-names></name><name name-style="western"><surname>Strittmatter</surname><given-names>SM</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>RGM and its receptor neogenin regulate neuronal survival.</article-title>             <source>Nat Cell Biol</source>             <volume>6</volume>             <fpage>749</fpage>             <lpage>755</lpage>          </element-citation></ref><ref id="pone.0000463-Galvan1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Galvan</surname><given-names>V</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D</given-names></name><name name-style="western"><surname>Logvinova</surname><given-names>A</given-names></name><name name-style="western"><surname>Goldsmith</surname><given-names>P</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Caspase cleavage of members of the amyloid precursor family of proteins.</article-title>             <source>J Neurochem</source>             <volume>82</volume>             <fpage>283</fpage>             <lpage>294</lpage>          </element-citation></ref><ref id="pone.0000463-Beher1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Beher</surname><given-names>D</given-names></name><name name-style="western"><surname>Hesse</surname><given-names>L</given-names></name><name name-style="western"><surname>Masters</surname><given-names>CL</given-names></name><name name-style="western"><surname>Multhaup</surname><given-names>G</given-names></name></person-group>             <year>1996</year>             <article-title>Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I.</article-title>             <source>J Biol Chem</source>             <volume>271</volume>             <fpage>1613</fpage>             <lpage>1620</lpage>          </element-citation></ref><ref id="pone.0000463-Caceres1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Caceres</surname><given-names>J</given-names></name><name name-style="western"><surname>Brandan</surname><given-names>E</given-names></name></person-group>             <year>1997</year>             <article-title>Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.</article-title>             <source>J Cell Biochem</source>             <volume>65</volume>             <fpage>145</fpage>             <lpage>158</lpage>          </element-citation></ref><ref id="pone.0000463-Williamson1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Williamson</surname><given-names>TG</given-names></name><name name-style="western"><surname>Mok</surname><given-names>SS</given-names></name><name name-style="western"><surname>Henry</surname><given-names>A</given-names></name><name name-style="western"><surname>Cappai</surname><given-names>R</given-names></name><name name-style="western"><surname>Lander</surname><given-names>AD</given-names></name><etal/></person-group>             <year>1996</year>             <article-title>Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth.</article-title>             <source>J Biol Chem</source>             <volume>271</volume>             <fpage>31215</fpage>             <lpage>31221</lpage>          </element-citation></ref></ref-list></back></article>